Zutripro

Zutripro is a brand name of chlorpheniramine/hydrocodone/pseudoephedrine, approved by the FDA in the following formulation(s):

ZUTRIPRO (chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride - solution; oral)

• 
  Manufacturer: CYPRESS PHARM
  
  Approval date: June 8, 2011
  
  Strength(s): 4MG/5ML;5MG/5ML;60MG/5ML ^[RLD]

Has a generic version of Zutripro been approved?

No. There is currently no therapeutically equivalent version of Zutripro available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zutripro. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Zutripro.

See also...

• Zutripro Consumer Information (Drugs.com)
• Zutripro Consumer Information (Cerner Multum)
• Zutripro Advanced Consumer Information (Micromedex)
• Chlorpheniramine/Hydrocodone/Pseudoephedrine Consumer Information (Wolters Kluwer)
• Chlorpheniramine/Hydrocodone/Pseudoephedrine Liquid Consumer Information (Wolters Kluwer)
• Chlorpheniramine, hydrocodone, and pseudoephedrine Consumer Information (Cerner Multum)
• Hydron PSC Advanced Consumer Information (Micromedex)
• Hydrocodone, chlorpheniramine, and pseudoephedrine Advanced Consumer Information (Micromedex)